Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BA/BE of ER Torsemide and Spironolactone FDC
NCT07046975Phase 3Completed
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of torasemide, spironolactone in edema, hypertension (HTN), heart failure (HF). Started Jun 2025; status: completed.
02
Drugs
torasemidespironolactone
03
Conditions
edemahypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT07046975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07046975.